11.12.26 -- Vendor Disruption, Dropout Risk, And What's Really Threatening Trial Timelines

Faster drafts aren't faster submissions. See how to apply AI across medical writing with the governance and human review regulators expect.

Global regulators are increasingly aligned, creating new opportunities for sponsors to pursue near-simultaneous submissions across major markets

Gain clarity on the rigorous statistical frameworks and E_max endpoint analyses required to evaluate drug abuse potential and satisfy complex regulatory safety standards.

If you want to increase speed and reduce costs while still procuring high-quality data for your clinical trial, consider the impact of launching an early-phase clinical trial in Australia.

Eye exams need calibrated equipment and trained staff. These three mobile delivery models bring that capability directly to your trial participants.

The FDA’s 2026 CDS guidance signals a shift to settled policy. IRBs must now demand greater transparency regarding automation bias and clinician independence to accurately assess study risk.

Built by research compliance experts, this platform streamlines the protocol-writing process through customizable templates, workflow tools, and collaboration support for research teams.

Retention, body composition, maintenance therapy, amylin combinations, and behavioral support are reshaping obesity trials. Learn how sponsors can reduce dropout risk and strengthen clinical data.

Master clinical vendor management with four key pillars: time, money, quality, and relationships. Learn which essential KPIs keep your trial timelines and budgets on track.

When vendors face disruptions, trials can be affected. Discover key questions to assess partner stability, strengthen operational resilience, and keep studies on track.

Hematology trials need strategies for complex endpoints, advanced therapies, and global compliance. Predictive analytics and tailored approaches accelerate timelines and optimize recruitment.

Overcome clinical transition challenges with integrated services, including study design, expert regulatory support, robust recruitment, and flexible manufacturing.

Inflammation is a primary pathogenic process in a wide range of diseases, including rheumatoid arthritis, cardiovascular disease, oncology and neuropsychiatric disorders.

Our dedicated team of in-house design specialists deliver insightful packaging design and practical knowledge to deliver differentiated and cost-effective packaging solutions.